InnoTech Precision Medicine, Inc
Boston, MA · Medtech · Private
Point-of-care diagnostic platform using CRISPR-Cas12 electrochemical detection with proprietary gold-leaf electrodes for HPV biomarker detection in saliva
- Grants
- $3.3M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $244K
- 1 award · Health and Human S
- #441 of 4531 in medtech
- Patents
- 12
- 1 granted · 11 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A multimodal platform for Oral screening of COVID-19 | $755,999 | |
| Federal grant | Department of Health and Human Services · Phase II · A multimodal platform for Oral screening of COVID-19 | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Point of care detection of HPV in saliva | $329,737 | |
| Federal contract | Department of Health and Human Services · Ncezid Topic 031 - Phase I Development Of Sherlock Assay | $243,500 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Development of a Microfluidic Device for Multi-Omics Diagnosis of Cancer | $305,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Point of Care Detection of HPV and P16 in Saliva | $1,414,853 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 438 | Specific Diagnostics, Inc. | $249K | $17M |
| 439 | Otolith Sound Inc | $248K | $31M |
| 440 | INSTADIAGNOSTICS INC | $244K | — |
| 441 | InnoTech Precision Medicine, Inc | $244K | — |
| 442 | Unlimited Tomorrow, Inc. | $237K | $6.7M |
| 443 | MicroMed, LLC | $237K | $950K |
| 444 | Maximum Fidelity Surgical Simulations, Inc. | $228K | $2.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods And Devices For Detection Of Orthogonal Classes Of Disease Biomarkersapplication
- Methods And Devices For Detection Of Orthogonal Classes Of Disease Biomarkersapplication
- Systems, Apparatus, And Methods For Detecting Pathogensapplication
- Systems, Apparatus, And Methods For Detecting Pathogensgranted
- Device And Method For Detecting Inflammationapplication
- Device And Method For Detecting Inflammationapplication
- Methods And Devices For Detection Of Orthogonal Classes Of Disease Biomarkersapplication
- Systems, Apparatus, And Methods For Detecting Pathogensapplication
- Methods And Devices For Detection Of Orthogonal Classes Of Disease Biomarkersapplication
- Device And Method For Detecting Inflammationapplication
- Device And Method For Detecting Pathogensapplication
- Device And Method For Detecting Pathogensapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.